Note: A hodgepodge of trials, added to as I come across them at work, during teaching or whilst preparing pages for this site. Interpretation of trial results is opinion (my own or my teachers’) and is included only as a prompt to read further and not as gospel.
Lead to widespread uptake of TXA in major haemorrhage
Death within 4 weeks of traumatic injury was reduced by 9% vs placebo
Survival advantage was seen when first dose given within 3 hours of the time of trauma
Comparison of 1:1 and 1:2 ratios of FFP:RBC in major haemorrhage
No difference in overall mortality.
Rate of post-operative sickle cell acute chest crisis was reduced by pre-op red cell transfusion for patient undergoing low to medium risk surgery. Only a small study but significant difference seen.
ACS occurred in 27% of untransfused, compared to 3% of transfused patients.